Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Satoshi, Hamanoue"'
Autor:
Yukari Sakurai, Fuminori Iwasaki, Ayana Hirose, Naoya Matsumoto, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Satoshi Hamanoue, Masakatsu Yanagimachi, Masae Shiomi, Shoko Goto, Mio Tanaka, Yukichi Tanaka, Kumiko Nozawa, Hiroaki Goto
Publikováno v:
Journal of Pediatric Hematology/Oncology; Jul2024, Vol. 46 Issue 5, p233-240, 8p
Autor:
Kosuke Tanaka, Shigeyoshi Yamanaga, Yuji Hidaka, Sho Nishida, Kohei Kinoshita, Akari Kaba, Toshinori Ishizuka, Satoshi Hamanoue, Kenji Okumura, Chiaki Kawabata, Mariko Toyoda, Akira Miyata, Masayuki Kashima, Hiroshi Yokomizo
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background Preoperative characteristics of living kidney donors are commonly considered during donor selection and postoperative follow-up. However, the impact of preoperative uric acid (UA) levels is poorly documented. The aim of this study
Externí odkaz:
https://doaj.org/article/cb94a301cb53408aace55a0b6da9ae45
Autor:
Sho Nishida, Yuji Hidaka, Mariko Toyoda, Kohei Kinoshita, Kosuke Tanaka, Chiaki Kawabata, Satoshi Hamanoue, Akito Inadome, Hiroshi Yokomizo, Asami Takeda, Soichi Uekihara, Shigeyoshi Yamanaga
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background The renal function of the remaining kidney in living donors recovers up to 60~70% of pre-donation estimated-glomerular filtration rate (eGFR) by compensatory hypertrophy. However, the degree of this hypertrophy varies from donor t
Externí odkaz:
https://doaj.org/article/92d18a1e019a4e5f85218c8255d42ca2
Autor:
Satoshi Hamanoue, Tatsuya Suwabe, Yoshifumi Ubara, Koichi Kikuchi, Ryo Hazue, Koki Mise, Toshiharu Ueno, Kenmei Takaichi, Kana Matsumoto, Kunihiko Morita
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Cyst infection is a common and serious complication of autosomal dominant polycystic kidney disease (ADPKD) that is often refractory. Carbapenems are frequently needed to treat to patients with refractory cyst infection, but littl
Externí odkaz:
https://doaj.org/article/1ea839384ea8495aacf8489186869df1
Autor:
Hiroaki Goto, Yukichi Tanaka, Ayana Hirose, Mieko Ito, Fuminori Iwasaki, Satoshi Hamanoue, Jun-ichi Nagai, Shoko Goto, Junko Takita, Hiroo Ueno, Yuki Yoshino, Tomoko Yokosuka, Dai Keino, Takashi Taga, Masakatsu Yanagimachi, Wataru Nakamura, Sachio Fujita, Yukari Sakurai, Akiko Hayashi, Naoyuki Miyagawa
Publikováno v:
British Journal of Haematology. 196:764-768
Approximately 20% of patients with transient abnormal myelopoiesis (TAM) die due to hepatic or multiorgan failure. To identify potential new treatments for TAM, we performed in vitro drug sensitivity testing (DST) using the peripheral blood samples o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5deb1d1e3b8c4bf4b727477ad5019fe
https://doi.org/10.1111/bjh.17970
https://doi.org/10.1111/bjh.17970
Autor:
Yukari Sakurai, Fuminori Iwasaki, Ayana Hirose, Naoya Matsumoto, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Satoshi Hamanoue, Masakatsu Yanagimachi, Masae Shiomi, Shoko Goto, Mio Tanaka, Yukichi Tanaka, Kumiko Nozawa, Hiroaki Goto
Background: Metronomic chemotherapy (MC) is based on chronic administration of chemotherapeutic agents at minimally toxic doses without prolonged drug-free breaks. MC has a multitargeted action of tumor angiogenesis inhibition and anticancer immune r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::031fe9f17185c7db0c2caf609ae9d24c
https://doi.org/10.22541/au.166852564.46859957/v1
https://doi.org/10.22541/au.166852564.46859957/v1
Autor:
Satoshi Hamanoue, Kotaro Suemitsu, Shina Sueki, Masashi Mukoyama, Hiroshi Nihei, Masaaki Murakami, Kengo Kajiwara, Kiyoshi Mori, Hideki Inoue, Masahito Miyamoto
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 61:998-1006
Objective Brachial artery transposition (BAT) is not a well known method for obtaining vascular access (VA) for maintenance haemodialysis. This study evaluated the outcomes of BAT. Methods This multicentre retrospective cohort study included 233 cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b97b4442c51b146eb4862a36b7dfb06
https://doi.org/10.1016/j.ejvs.2021.01.038
https://doi.org/10.1016/j.ejvs.2021.01.038
Autor:
Akari Kaba, Mariko Toyoda, Hiroshi Yokomizo, Sho Nishida, Shigeyoshi Yamanaga, Toshinori Ishizuka, Yuji Hidaka, Kohei Kinoshita, Akira Miyata, Masayuki Kashima, Chiaki Kawabata, Satoshi Hamanoue, Kenji Okumura, Kosuke Tanaka
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 22, Iss 1, Pp 1-11 (2021)
BMC Nephrology, Vol 22, Iss 1, Pp 1-11 (2021)
BackgroundPreoperative characteristics of living kidney donors are commonly considered during donor selection and postoperative follow-up. However, the impact of preoperative uric acid (UA) levels is poorly documented. The aim of this study was to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47aec69e3e125a826760af719a09297b
http://europepmc.org/articles/PMC7953616
http://europepmc.org/articles/PMC7953616
Autor:
Takesi Inukai, Yukari Sakurai, Mieko Ito, Tadashi Kumamoto, Tomoko Yokosuka, Jun-ichi Nagai, Fuminori Iwasaki, Yuki Yoshino, Shoko Goto, Dai Keino, Satoshi Hamanoue, Masae Shiomi, Hiroaki Goto, Naoyuki Miyagawa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:1055-1056
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd798dae2e2f621cf3111dae8d368055
https://doi.org/10.1007/s00280-021-04321-2
https://doi.org/10.1007/s00280-021-04321-2
Autor:
Dai Keino, Shoko Goto, Sachio Fujita, Yukichi Tanaka, Naoyuki Miyagawa, Hiroaki Goto, Fuminori Iwasaki, Akiko Hayashi, Masae Shiomi, Yukari Sakurai, Masakatsu Yanagimachi, Kumiko Nozawa, Norihiko Kitagawa, Tomoko Yokosuka, Ayana Hirose, Satoshi Hamanoue, Mio Tanaka, Wataru Nakamura
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(11)
Background Preclinical observations suggested a synergistic effect of sorafenib (SFN) and irinotecan (CPT-11) in hepatoblastoma (HB). Thus, we conducted a feasibility study of fractionated CPT-11 combined with SFN to develop a new therapy against rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff350030106776942cbdc5eb50e81df
https://pubmed.ncbi.nlm.nih.gov/32798298
https://pubmed.ncbi.nlm.nih.gov/32798298